Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 2 40-2, 1996, Pages

  Balcells, Eduardo ^b   Meng, Qing C ^b   Hageman, Gilbert R ^b   Palmer, Ronald W ^b   Durand, Joan N ^b   Dell'Italia, Louis J ^a  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

cardiac renin angiotensin system

Indexed keywords

ANGIOTENSIN; CAPTOPRIL; CHYMOSTATIN;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CORONARY BLOOD VESSEL; DOG; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 33750707643     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.2.h417     Document Type: Article

References (23)

1. Cushman, D. W.,and H. S. Cheung. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20: 1637-1648, 1971.
2. Danser, A. H. J.,L. M. de Lannoy, R. M. Schoemaker, P. R. Saxena, and M. A. D. H. Schalekamp. Renin-angiotensin system components in cardiac interstitial fluid. Uptake from plasma and local production (Abstract). Circulation 90, Suppl. I: I-342, 1994.
3. Dell'Italia, L. J.,Q. C. Meng, E. Balcells, I. M. Straeter-Knowlen, G. H. Hankes, R. Dillon, R. E. Cartee, R. Orr, S. P. Bishop, S. Oparil, and T. S. Elton. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H2065-H2073, 1995.
4. Dzau, V. J. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities, and hypotheses. J. Hypertens. 7: 933-936, 1989.
5. Frank, M. J.,M. Nadimi, P. Casanegra, P. Stein, and R. Pekaar. Effect of angiotensin on myocardial function. Am. J. Physiol. 218: 1267-1278, 1970.
6. Friedrich, S. P.,B. H. Lorell, M. F. Rousseau, W. Hayashida, O. M. Hess, P. S. Douglas, S. Gordon, C. S. Keighley, C. Benedict, H. P. Krayenbuehl, W. Grossman, and H. Pouleur. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 90: 2761-2771, 1994.
7. Hoit, B.,Y. Shao, A. Kinoshita, M. Gabel, A. Hussain, and R. A. Walsh. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon. J. Clin. Invest. 95: 1519-1527, 1995.
8. Husain, A. The chymase-angiotensin system in humans. Hypertension Dallas 11: 1155-1159, 1993.
9. Husain, A.,A. Kinoshita, S. S. Sung, H. Urata, and F. M. Bumpus. The Cardiac Renin-Angiotensin System. Armonk, NY: Futura Publishing, 1994, p. 309-332.
10. Johnston, C. I. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension Dallas 23: 258-268, 1994.
11. Kinoshita, A.,H. Urata, F. M. Bumpus, and A. Husain. Multiple determinants for the high substrate specificity of an angiotensin-forming chymase from the human heart. J. Biol. Chem. 266: 19192-19197, 1991.
12. 12)-angiotensin I. Hypertension Dallas 23: 857-860, 1994.
13. Meng, Q. C.,J. Durand, Y. Chen, and S. Oparil. Simplified method for quantification of angiotensin peptides in tissue. J. Chromatogr. 614: 19-25, 1993.
14. Meng, Q. C.,J. Durand, Y. Chen, and S. Oparil. Effects of dietary salt on angiotensin peptides in kidney. J. Am. Soc. Nephrol. 6: 1209-1215, 1995.
15. Noda, K.,M. Sasaguri, M. Ideishi, M. Ikeda, and K. Arakawa. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Circ. Res. 27: 334-340, 1993.
16. Okunishi, H.,Y. Oka, N. Shiota, T. Kawamoto, K. Song, and M. Miyazaki. Marked species-difference in the vascular angiotensin II-forming pathways: humans vs. rodents. Jpn. J. Pharmacol. 62: 207-210, 1993.
17. Pfeffer, M. A.,E. Braunwald, L. A. Moyé, L. Basta, E. J. Brown, Jr.,T. E. Cuddy, B. R. Davis, E. M. Geltman, S. Goldman, G. C. Flaker, M. Klein, G. A. Lamas, M. Packer, J. Rouleau, J. L. Rouleau, J. Rutherford, J. H. Wertheimer, C. M. Hawkins, and the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327: 669-677, 1992.
18. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327: 685-691, 1992.
19. Urata, H.,K. D. Boehm, A. Philip, A. Kinoshita, J. Gabrovsek, F. M. Bumpus, and A. Husain. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J. Clin. Invest. 91: 1269-1281, 1993.
20. Urata, H.,B. Healy, R. W. Stewart, F. M. Bumpus, and A. Husain. Angiotensin II-forming pathways in normal and failing human hearts. Circ. Res. 66: 883-890, 1990.
21. Urata, H.,A. Kinoshita, K. S. Misono, F. M. Bumpus, and A. Husain. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265: 22348-22357, 1990.
22. Urata, H.,A. Kinoshita, D. M. Perez, K. S. Misono, F. M. Bumpus, R. M. Graham, and A. Husain. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem. 266: 17173-17179, 1991.
23. Zisman, L. S.,W. T. Abraham, G. E. Meixell, B. N. Vamvakias, R. A. Quaife, B. D. Lowes, R. L. Roden, S. J. Peacock, B. M. Groves, M. R. Bristow, and M. B. Perryman. Angiotensin II formation in the intact human heart: predominance of the angiotensin converting enzyme pathway. J. Clin. Invest. 95: 1490-1498, 1995.